How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study

Global Health Research and Policy · Published 2025-08-26 · DOI 10.1186/s41256-025-00434-w

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1186/s41256-025-00434-w

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles